205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.31%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.07%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.06%
Negative EBIT growth while QCOM is at 208.56%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-9.04%
Negative operating income growth while QCOM is at 208.56%. Joel Greenblatt would press for urgent turnaround measures.
-1.78%
Negative net income growth while QCOM stands at 316.63%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Negative diluted EPS growth while QCOM is at 348.57%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.47%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.44%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.16%
Dividend reduction while QCOM stands at 1.03%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-48.39%
Negative OCF growth while QCOM is at 181.65%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-53.02%
Negative FCF growth while QCOM is at 134.29%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
133.94%
10Y revenue/share CAGR at 75-90% of QCOM's 162.15%. Bill Ackman would press for new markets or product lines to narrow the gap.
38.70%
5Y revenue/share CAGR above 1.5x QCOM's 1.75%. David Dodd would look for consistent product or market expansions fueling outperformance.
28.08%
3Y revenue/share CAGR above 1.5x QCOM's 3.82%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
498.85%
Positive long-term OCF/share growth while QCOM is negative. John Neff would see a structural advantage in sustained cash generation.
175.85%
Positive OCF/share growth while QCOM is negative. John Neff might see a comparative advantage in operational cash viability.
116.94%
Positive 3Y OCF/share CAGR while QCOM is negative. John Neff might see a big short-term edge in operational efficiency.
9620.45%
Net income/share CAGR above 1.5x QCOM's 326.80% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
187.69%
Positive 5Y CAGR while QCOM is negative. John Neff might view this as a strong mid-term relative advantage.
83.48%
Positive short-term CAGR while QCOM is negative. John Neff would see a clear advantage in near-term profit trajectory.
25.60%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-7.65%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-6.64%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
597.21%
Dividend/share CAGR of 597.21% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
156.46%
5Y dividend/share CAGR above 1.5x QCOM's 76.90%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
102.64%
3Y dividend/share CAGR above 1.5x QCOM's 29.52%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
19.30%
AR growth well above QCOM's 17.98%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.88%
Inventory is declining while QCOM stands at 0.30%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.79%
Asset growth well under 50% of QCOM's 4.77%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-3.87%
We have a declining book value while QCOM shows 354.67%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
21.41%
Debt growth far above QCOM's 0.10%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.75%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
No Data
No Data available this quarter, please select a different quarter.